Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds

In order to clarify the onset mechanisms of drug-induced allergies, three fluorescent-labelled compounds were synthesized by subjecting sulfanilamide (SA), a base compound for sulfonamides, and its active metabolites, i.e. sulfanilamide hydroxylamine and sulfanilamide nitroso, to dansylation using dansylchloride. In other words, 5-dimethylamino-N-(4-aminobenzyl)-naphthalenesulfonamide (DNS-4ABA), 5-dimethylamino-N-(4-hydroxylaminobenzyl)-1-naphthalenesulfonamide (DNS-4HABA) and 5-dimethylamino-N-(4-nitrosobenzyl)-1-naphthalenesulfonamide (DNS-4NSBA) were synthesized as model haptens. When analysed by HPLC, a conjugate of DNS-4HABA and glutathione (GSH) with nucleophilic amino acids had two peaks (P-1 and P-2). FAB-MS and 1H-NMR revealed that the DNS-4HABA-GSH conjugate consisted of sulphinamide and semimercaptal. The reactivity of GSH to DNS-4ABA, DNS-4HABA and DNS-4NSBA was quantified by HPLC using an oxidization system (horseradish peroxidase/H2O2). The results show that production of DNS-4NSBA-GSH-conjugate was four to eight times higher than that of DNS-4HABA-GSH conjugate, but that DNS-4ABA did not bind with GSH. Skin reactions were assessed using guinea pigs, and strong delayed erythema was seen with DNS-4NSBA, which bound most strongly with GSH, whereas weak delayed erythema was seen with DNS-4ABA, which did not bind with GSH. This suggests a correlation between GSH conjugate production and skin reactions. DNS-4HABA enzymatically bound with proteins in rat and guinea pig liver cytosol and microsomal fractions. The proteins that bound to DNS-4HABA were purified by HPLC and then subjected to N-terminal amino acid analysis. Ubiquitin (10 kDa) and fatty acid binding protein (30 kDa) were detected in the rat liver cytosol fraction; retinol-dehydrogenase (35 kDa) in the rat microsomal fraction; and glutathione-S-transferase B (mμ) (25 kDa) in the guinea pig liver cytosol fraction. When DNS-4HABA or DNS-4NSBA binds to proteins that play important roles in the body, unexpected adverse reactions may occur. Furthermore, by utilizing our technique using model compounds, it may be possible to identify the carrier proteins of various compounds, including pharmaceutical agents.

[1]  Candace Black-Schaefer,et al.  Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays. , 2004, Rapid communications in mass spectrometry : RCM.

[2]  M. Rieder,et al.  Haptenation of sulfonamide reactive metabolites to cellular proteins. , 2002, Molecular pharmacology.

[3]  M. Pirmohamed,et al.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation in vivo , 2001, British journal of pharmacology.

[4]  M Pirmohamed,et al.  Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity , 1999, British journal of pharmacology.

[5]  S. Valitutti,et al.  HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. , 1998, The Journal of clinical investigation.

[6]  S. Imaoka,et al.  Cloning and characterization of the CYP2D1-binding protein, retinol dehydrogenase. , 1998, Archives of biochemistry and biophysics.

[7]  D. Skiest,et al.  Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole. , 1998, The Journal of allergy and clinical immunology.

[8]  J. Leeder,et al.  Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins. , 1997, The Journal of pharmacology and experimental therapeutics.

[9]  M. Pirmohamed,et al.  The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[10]  C. Brander,et al.  Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. , 1995, Journal of immunology.

[11]  J. L. Napoli,et al.  Cloning of a cDNA for Liver Microsomal Retinol Dehydrogenase , 1995, The Journal of Biological Chemistry.

[12]  M. Rieder,et al.  Time-course of toxicity of reactive sulfonamide metabolites. , 1995, Toxicology.

[13]  R. Gruchalla,et al.  Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins. , 1994, The Journal of allergy and clinical immunology.

[14]  A. Varshavsky.  The N-end rule , 1992, Cell.

[15]  M. Miller,et al.  Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[16]  R. Eyanagi,et al.  Studies of paracetamol/phenacetin toxicity: isolation and characterization of p-aminophenol-glutathione conjugate. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[17]  J. Veerkamp,et al.  Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. , 1991, Biochimica et biophysica acta.

[18]  S. Spielberg,et al.  Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[19]  R. Oshino,et al.  Purification and characterization of glutathione S-transferases from guinea pig liver. , 1990, Journal of biochemistry.

[20]  R. Oshino,et al.  Amino acid sequence of glutathione S-transferase b from guinea pig liver. , 1990, Journal of biochemistry.

[21]  A. Hershko.  Ubiquitin-mediated protein degradation. , 1988, The Journal of biological chemistry.

[22]  R. Patterson,et al.  Management of drug allergy in patients with acquired immunodeficiency syndrome. , 1987, The Journal of allergy and clinical immunology.

[23]  J. Uetrecht.  Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide. , 1985, The Journal of pharmacology and experimental therapeutics.

[24]  H. Yoshimura,et al.  Enhancement of sulfanilamide N4-hydroxylase activity in kidney and liver microsomes of rats by pretreatment with 3-methylcholanthrene type-polychlorinated biphenyl. , 1982, Journal of pharmacobio-dynamics.

[25]  T. Kudo,et al.  Reduction with Sodium Borohydride-Transition Metal Salt Systems. I. Reduction of Aromatic Nitro Compounds with the Sodium Borohydride-Nickelous Chloride System , 1981 .

[26]  R. Eyanagi,et al.  [Experimental studies on the antigenicity of some metabolites and related compounds of sulfanilamide (author's transl)]. , 1979, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[27]  I. Arias,et al.  Ligandin. Bilirubin binding and glutathione-S-transferase activity are independent processes. , 1978, The Journal of biological chemistry.

[28]  R. Eyanagi,et al.  Positive skin reaction induced by 4,4'-azoxybenzenedisulfonamide in relationship to the sulfanilamide allergy. , 1977, International archives of allergy and applied immunology.

[29]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.